Drug recall D-0621-2020
Product
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
Reason for recall
Sub Potent Drug: Out of Specification (OOS)
Lots and codes
Pacira Lot #: 19-5002, Patheon manufacturer Lot #: 098214; Exp. Date: Dec 2019
Recall details
- Recalling firm
- Pacira Pharmaceuticals, Inc., San Diego, CA
- Quantity
- 910 20 mL vials
- Distribution
- Distributed Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 21, 2019
- Terminated
- June 3, 2020
Related products
- Exparel – drug information
- NDC 65250-133 Exparel · Bupivacaine 13.3 mg/mL · Pacira Pharmaceuticals, Inc.
- NDC 65250-266 Exparel · Bupivacaine 13.3 mg/mL · Pacira Pharmaceuticals, Inc.